论文标题

特定于患者的建模,模拟和实时处理呼吸道疾病

Patient-specific modelling, simulation and real-time processing for respiratory diseases

论文作者

Nousias, Stavros

论文摘要

哮喘是呼吸系统的常见慢性疾病,导致严重的残疾和社会负担。它影响了全球超过3亿人,到2025年,超过1亿人可能患有哮喘。哮喘的价格因国家而异。欧洲的平均年每年费用估计为1900欧元,在美国为3100美元。管理哮喘涉及控制症状,预防加重和保持肺功能。改善的哮喘控制是降低了加重和肺功能障碍的风险,同时降低了哮喘护理的直接成本和与生产率降低相关的间接成本。了解肺系统的复杂动力学和肺对疾病的反应是哮喘治疗的发展。呼吸系统的计算模型试图提供一个理论框架,以了解结构与功能之间的相互作用。他们的应用可以通过特定于患者的药物学方法来改善肺部医学,以优化鉴于个性化几何形状和个性化通风模式,以优化分娩。在本文中解决了一个三倍的目标。第一部分是指对肺病理生理学的理解以及哮喘的力学以及随后的肺部疾病的理解。第二部分是指促进个性化医学以提高分娩和有效性的工具的设计和实施。最后,第三部分是指疾病的自我管理,这意味着医务人员和患者可以使用工具和方法,使第一方可以轻松地跟踪病情和第二方的过程,即患者可以轻松地自我管理,从而减轻了卫生系统的巨大负担。

Asthma is a common chronic disease of the respiratory system causing significant disability and societal burden. It affects more than 300 million people worldwide, while more than 100 million people will likely have asthma by 2025. The price of asthma varies greatly from nation to nation. Mean yearly cost can be estimated to 1900 EUR in Europe and $3100 in the United States. Managing asthma involves controlling symptoms, preventing exacerbations, and maintaining lung function. Improved asthma control is reduces the risk of exacerbations and lung function impairment while reducing the direct costs of asthma care and indirect costs associated with reduced productivity. Understanding the complex dynamics of the pulmonary system and the lung's response to disease is fundamental to the advancement of Asthma treatment. Computational models of the respiratory system seek to provide a theoretical framework to understand the interaction between structure and function. Their application can improve pulmonary medicine by a patient-specific approach to medicinal methodologies optimizing the delivery given the personalized geometry and personalized ventilation patterns. A three-fold objective is addressed within this dissertation. The first part refers to the comprehension of pulmonary pathophysiology and the mechanics of Asthma and subsequently of constrictive pulmonary conditions in general. The second part refers to the design and implementation of tools that facilitate personalized medicine to improve delivery and effectiveness. Finally, the third part refers to the self-management of the condition, meaning that medical personnel and patients have access to tools and methods that allow the first party to easily track the course of the condition and the second party, i.e. the patient to easily self-manage it alleviating the significant burden from the health system.

扫码加入交流群

加入微信交流群

微信交流群二维码

扫码加入学术交流群,获取更多资源